During recent years there has been substantial demand by Licensed Producers to better understand the pharmacology and therapeutic potential of their strains and related products.
Cannevert Therapeutics (CTL), has assembled a leading team of highly skilled experts in the fields of chemistry and pharmacology, with substantial experience inthe pharmaceutical industry. This level of expertise is rarely available outside leading pharmaceuticals and even less available to Licensed Producers in need of validating the efficacy of their therapeutic claims. CTL is developing technics to profile cannabis strains from one batch to another, especially strains utilized for medical purposes. Providing the ability to develop monographs based on the results and continue to monitor various batches for consistency.
Chemical and Microbial Analysis
Ensuring patient safety, providing a chemical footprint of your cannabis
Tests will quantify presence of THC, THCA, CBDA, CBD, CBN, and other relevant cannabinoids across various cannabis batches and strains.
Almost all cannabis samples will include bacterial, fungal, and other microorganisms with potential to harm patients, our quality screens will provide you with a list of identified microbial presence.
In addition to cannabinoids, terpenes have been shown to have therapeutic value. Our screens will assist you to profile presence of terpenes as well as cannabinoids, to help you better unlock the therapeutic value of your cannabis strains.
Testing for naturally occurring toxins and carcinogens in accordance with Health Canada requirements.
Heavy metals can potentially accumulate in cannabis batches through water or soil, our metal analysis will identify presence of lead, mercury, cadmium, and chromium.
Residual Solvent Analysis
Our screens will also identify presence of harmful chemicals, solvents, and impurities.
A report of potentially harmful pesticides in your samples is provided, to ensure harm prevention.
Biological and Clinical Assessment
Establishing the real therapeutic value of your cannabis products
Cannevertis in the process of developing and refining biological assays that address the following areas of industry interest:
in vivo Pharmacology:
- Cardiovascular safety models
- Lung safety models
- Pain models (acute, chronic)
- Emesis models (Nausea and Vomiting)
- Behavioural models
- Sleep model
- Glaucoma model
in vitro Pharmacology:
- Cancer cell models
- Electrophysiology – brain and heart cells
Cannevert clinical scientists can also design and implement clinical studies that address the following areas of industry interest:
Proof-of-Concept Studies in Healthy Subjects and Patients in Areas of:
- Simulated Pain
- Optimal Dosage and Frequency
- Product Delivery Device Compatibility
Clinical Patient Studies in Areas of:
- Hear and Lung Safety Assessments
- Acute and Chronic Pain
- Seniors/Palliative Care
The above information can serve as the basis for a product monograph: chemical, biological and clinical identity on the safety and efficacy; in addition to the, clinical utility (dosage and frequency) of your cannabis strains from batch to batch.